Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer

Journal Article

Nov 24

Written By Simran Padam

The Onclologist

View publication ↗

Oncology Clinical DevelopmentBreast CancerTriple-Negative Breast CancerImmunotherapyClinical Trials

Simran Padam

Phase II Study of Neratinib in Older Adults with HER2 Amplified or HER2/3 Metastatic Breast Cancer

Older Adult Participation in Cancer Clinical Trials: A Systematic Review of Barriers and Interventions